Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.

Saved in:
Bibliographic Details
Title: Author Correction: PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.
Authors: Thura M; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore., Al-Aidaroos AQ; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore., Gupta A; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore., Chee CE; Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore., Lee SC; Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore., Hui KM; Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, 169610, Singapore., Li J; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore., Guan YK; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119260, Singapore., Yong WP; Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore., So J; Division of Surgical Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore., Chng WJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore., Ng CH; Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore., Zhou J; Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore., Wang LZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Yuen JSP; Department of Urology, Singapore General Hospital, Singapore, 169608, Singapore., Ho HSS; Department of Urology, Singapore General Hospital, Singapore, 169608, Singapore., Yi SM; Department of Urology, Singapore General Hospital, Singapore, 169608, Singapore., Chiong E; Division of Surgical Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore., Choo SP; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore., Ngeow J; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, 308232, Singapore., Ng MCH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore., Chua C; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore., Yeo ESA; Department of Colorectal Surgery, Singapore General Hospital, Singapore, 169608, Singapore., Tan IBH; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore., Sng JXE; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore., Tan NYZ; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore., Thiery JP; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore., Goh BC; Department of Haematology-Oncology, National University Cancer Institute, Singapore (NCIS), Singapore, 119082, Singapore., Zeng Q; Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, 138673, Singapore. mcbzengq@imcb.a-star.edu.sg.; Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119260, Singapore. mcbzengq@imcb.a-star.edu.sg.
Source: Nature communications [Nat Commun] 2021 Nov 02; Vol. 12 (1), pp. 6431. Date of Electronic Publication: 2021 Nov 02.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-021-26548-6